Stock APLS APELLIS PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Relative Strength Chart Apellis Pharmaceuticals, Inc.

Equities

APLS

US03753U1060

Delayed Nasdaq
Other stock markets
 15:50:03 2024-05-10 EDT 		5-day change 1st Jan Change
42.24 USD -0.66% Intraday chart for Apellis Pharmaceuticals, Inc. -10.81% -29.28%
05-09 Apellis Pharmaceuticals Insider Sold Shares Worth $3,341,848, According to a Recent SEC Filing MT
05-08 UBS Adjusts Price Target on Apellis Pharmaceuticals to $85 From $89, Maintains Buy Rating MT

End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
APELLIS PHARMACEUTICALS, INC.
Biopharmaceuticals
-0.66%-10.81%-29.28%-53.68%+121.86% 5.16B
Bearish
Bearish
Neutral
  1. Stock Market
  2. Equities
  3. APLS Stock
  4. Charts Apellis Pharmaceuticals, Inc.
  5. Relative Strength Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW